Answers are grounded in this paper and cite their sources.
This cohort study evaluates the implications of copayment assistance discontinuation for treatment strategies and clinical outcomes in patients needing high-cost anti–vascular endothelial growth factor drugs for neovascular age-related macular degeneration.
No takes yet. Share an insight, caveat, or question.
Carrera et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: